TGR-1202 (Umbralisib)
目录号: A16277
PI3Kδ inhibitor
TGR-1202 是一种口服的新一代 PI3Kδ 抑制剂,在酶和细胞基础的测定中抑制 PI3Kδ 活性,其 IC50 和 EC50 值分别为 22.2 和 24.3 nM。
Discription | TGR-1202 is an orally available, next generation PI3Kδ inhibitor, inhibits PI3Kδ activity in enzyme and cell based assays with IC50 and EC50 values of 22.2 and 24.3 nM respectively. | ||
---|---|---|---|
Targets |
|
目录号 | A16277 |
---|---|
分子式 | C31H24F3N5O3 |
分子量 | 571.55 |
CAS号 | 1532533-67-7 |
SMILES | CC(C)OC1=C(C=C(C=C1)C2=NN(C3=C2C(=NC=N3)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F |
其他名称 | RP5264, TGR1202, TGR 1202, RP-5264, RP 5264 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Warmed: 92 mg/mL (160.96 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 6 mg/mL | ||
In vivo | 2% DMSO+30% PEG 300+2% Tween 80+H2O | 2 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.5 mL | 87.48 mL | 174.96 mL |
0.5 mM | 3.5 mL | 17.5 mL | 34.99 mL |
1 mM | 1.75 mL | 8.75 mL | 17.5 mL |
5 mM | 0.35 mL | 1.75 mL | 3.5 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2